Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: A double-blind, randomised, controlled trial

Elena Neri, Alessandra Maestro, Federico Minen, Marcella Montico, Luca Ronfani, Davide Zanon, Anna Favret, Gianni Messi, Egidio Barbi

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives To assess the effectiveness of sublingual ketorolac versus sublingual tramadol in reducing the pain associated with fracture or dislocation of extremities in children. Patients and methods A double-blind, randomised, controlled, non-inferiority trial was conducted in the paediatric emergency department of a research institute. One hundred and thirty-one children aged 4-17 years with suspected bone fracture or dislocation were enrolled. Eligible children were randomised to ketorolac (0.5 mg/kg) and placebo, or to tramadol (2 mg/kg) and placebo by sublingual administration, using a doubledummy technique. Pain was assessed by the patients every 20 min, for a maximum period of 2 h, using the McGrath scale for patients up to 6 years of age, and the Visual Analogue Scale for those older than 6 years of age. Results The mean pain scores fell significantly from eight to four and five in the ketorolac and tramadol groups, respectively, by 100 min (Wilcoxon sign rank test, p

Original languageEnglish
Pages (from-to)721-724
Number of pages4
JournalArchives of Disease in Childhood
Volume98
Issue number9
DOIs
Publication statusPublished - Sep 2013

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: A double-blind, randomised, controlled trial'. Together they form a unique fingerprint.

Cite this